DIVI S LABORATORIES LTD vs JUPITER LIFE LINE HOSP L

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and JUPITER LIFE LINE HOSP L (JLHL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs JLHL on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
52.48
10.72
P/B ratio
6.16
0.44%
Dividend yield
0.07%
₹96.73
EPS
₹29.59

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
13.10%
22.00%
Return on capital
15.00%
33.00%
EBITDA margin
23.00%
24.32%
Net margin
12.93%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
18.87%
12.10%
Profit CAGR (3Y)
38.51%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹10,199 Cr
₹10,560 Cr
Revenue
₹1,500 Cr
₹2,568 Cr
Net profit
₹194 Cr
0.00
Debt / equity
0.38
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
JUPITER LIFE LINE HOSP L
  • + ["Company has delivered good profit growth of 143% CAGR over last 5 years"]
  • ["Working capital days have increased from 24.3 days to 97.4 days"]
DIVI S LABORATORIES LTD full analysis JUPITER LIFE LINE HOSP L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVI S LABORATORIES LTD vs JUPITER LIFE LINE HOSP L: Share Price, Valuation & Which to Buy | DocStoX